News & Analysis as of

Rulemaking Process › Department of Justice (DOJ) › Schedule I Drugs

Bradley Arant Boult Cummings LLP

DEA Judge Overseeing Rescheduling Process Retires, Further Casting Doubt on the Likelihood of Any Change in the Near Term

Bradley Arant Boult Cummings LLP on

We’ve written before that with rescheduling, with all of the excitement and pomp and circumstance that came with its announcement in the last year of the Biden administration, the whole thing was beginning to look like it may...more

McDermott Will & Schulte

DOJ Proposes to Reschedule Marijuana (Cannabis) to Schedule III

McDermott Will & Schulte on

On May 21, 2024, the US Department of Justice (DOJ) published the highly anticipated notice of proposed rulemaking (NPRM) to reschedule marijuana (cannabis) from a Schedule I controlled substance to Schedule III, taking the...more

Holland & Hart LLP

Colorado's Proposition 122: Too soon for the mushroom boom?

Holland & Hart LLP on

In November 2022, Colorado passed Proposition 122 (Prop 122), arguably one of the nation's first "legalize and regulate" natural psychedelic medicine laws, and people are already filled with romantic images of magic mushroom...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide